Expecting the unexpected: diagnostic imaging of side effects due to cancer treatment in children
Pediatric oncological treatments significantly improved in the last decades with a significant positive impact on survival rates. Despite these achievements, cancer therapy is affected by side effects which may represent a diagnostic challenge and influence the overall management of children with tumors. Diagnostic imaging plays a crucial role in diagnosing adverse events, distinguishing them also from potential mimickers like infections or recurrences. Radiologists and nuclear medicine physicians are expected to have a deep knowledge of the common therapeutic schemes, their potential side effects, and features at imaging. Therefore, the aim of this review is to provide a comprehensive overview of the role of imaging, including hybrid techniques, in correctly identifying and characterizing the side effects of cancer treatment in children, including a brief overview of the main therapeutic options in pediatric oncology.
Authors
- Francesco Causin
- Piero Farruggia (ORCID: https://orcid.org/0000-0002-3412-0399)
- Monica Zuliani
- Chiara Giraudo (ORCID: https://orcid.org/0000-0003-0924-5883)
- Roberto Stramare (ORCID: https://orcid.org/0000-0002-1818-2290)
- D. Cecchin
- Alessandro Di Paola (ORCID: https://orcid.org/0000-0002-7957-3092)
- Giulia Fichera (ORCID: https://orcid.org/0000-0003-2977-5304)
- Anna Michielin
- Francesca Serani
- Gianni Bisogno
Institutions
- University of Padua (IT)
Publication Details
- Journal
- Clinical and Translational Imaging
- Published
- 2026-02-16
- DOI
- https://doi.org/10.1007/s40336-026-00752-0
- Primary Topic
- Neuroblastoma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Università degli Studi di Padova